Advertisement

Index by Author

January 1990; 39 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Adkins-Marshall, B A

    • Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes January 1990 39:87-95; doi:10.2337/diabetes.39.1.87

  2. Andoh, Y

    • Immediate elimination of labile HbA1c with allosteric effectors of hemoglobin. Diabetes January 1990 39:17-21; doi:10.2337/diabetes.39.1.17

B

  1. Bell, G I

    • Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction. Diabetes January 1990 39:123-128; doi:10.2337/diabetes.39.1.123

  2. Bergstrom, R W

    • Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes January 1990 39:104-111; doi:10.2337/diabetes.39.1.104

  3. Betsholtz, C

    • Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes January 1990 39:118-122; doi:10.2337/diabetes.39.1.118

  4. Black, P R

    • Adenosine reversal of in vivo hepatic responsiveness to insulin. Diabetes January 1990 39:62-69; doi:10.2337/diabetes.39.1.62

  5. Brechtel, G

    • Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects. Diabetes January 1990 39:22-30; doi:10.2337/diabetes.39.1.22

  6. Bugawan, T L

    • HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes January 1990 39:96-103; doi:10.2337/diabetes.39.1.96

  7. Bunchman, T E

    • Effect of cyclosporin on generalized Shwartzman reaction in diabetic rats. Diabetes January 1990 39:83-86; doi:10.2337/diabetes.39.1.83

C

  1. Carter, W G

    • Occurrence of type VI collagen in extracellular matrix of renal glomeruli and its increase in diabetes. Diabetes January 1990 39:31-37; doi:10.2337/diabetes.39.1.31

  2. Castellino, P

    • Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes January 1990 39:38-48; doi:10.2337/diabetes.39.1.38

  3. Cherrington, A D

    • Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes January 1990 39:87-95; doi:10.2337/diabetes.39.1.87

  4. Chou, H F

    • Pulsatile insulin secretion in isolated rat islets. Diabetes January 1990 39:112-117; doi:10.2337/diabetes.39.1.112

  5. Christmanson, L

    • Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes January 1990 39:118-122; doi:10.2337/diabetes.39.1.118

  6. Crepaldi, G

    • Absence of brown product FFI in nondiabetic and diabetic rat collagen. Diabetes January 1990 39:57-61; doi:10.2337/diabetes.39.1.57

D

  1. DeFronzo, R A

    • Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes January 1990 39:38-48; doi:10.2337/diabetes.39.1.38

  2. Del Favero, E

    • Absence of brown product FFI in nondiabetic and diabetic rat collagen. Diabetes January 1990 39:57-61; doi:10.2337/diabetes.39.1.57

E

  1. Engström, U

    • Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes January 1990 39:118-122; doi:10.2337/diabetes.39.1.118

  2. Erlich, H A

    • HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes January 1990 39:96-103; doi:10.2337/diabetes.39.1.96

F

  1. Fedele, D

    • Absence of brown product FFI in nondiabetic and diabetic rat collagen. Diabetes January 1990 39:57-61; doi:10.2337/diabetes.39.1.57

  2. Floyd, B

    • Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes January 1990 39:87-95; doi:10.2337/diabetes.39.1.87

  3. Fujimoto, W Y

    • Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes January 1990 39:104-111; doi:10.2337/diabetes.39.1.104

G

  1. Gerhardinger, C

    • Absence of brown product FFI in nondiabetic and diabetic rat collagen. Diabetes January 1990 39:57-61; doi:10.2337/diabetes.39.1.57

  2. Griffith, R L

    • HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes January 1990 39:96-103; doi:10.2337/diabetes.39.1.96

  3. Gumbiner, B

    • Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects. Diabetes January 1990 39:22-30; doi:10.2337/diabetes.39.1.22

H

  1. Hattori, Y

    • Immediate elimination of labile HbA1c with allosteric effectors of hemoglobin. Diabetes January 1990 39:17-21; doi:10.2337/diabetes.39.1.17

  2. Hendrick, G K

    • Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes January 1990 39:87-95; doi:10.2337/diabetes.39.1.87

  3. Henry, R R

    • Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects. Diabetes January 1990 39:22-30; doi:10.2337/diabetes.39.1.22

I

  1. Ipp, E

    • Pulsatile insulin secretion in isolated rat islets. Diabetes January 1990 39:112-117; doi:10.2337/diabetes.39.1.112

J

  1. Johnson, K H

    • Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes January 1990 39:118-122; doi:10.2337/diabetes.39.1.118

  2. Jordan, K

    • Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes January 1990 39:118-122; doi:10.2337/diabetes.39.1.118

K

  1. Kaku, K

    • Polymorphisms of HepG2/erythrocyte glucose-transporter gene. Linkage relationships and implications for genetic analysis of NIDDM. Diabetes January 1990 39:49-56; doi:10.2337/diabetes.39.1.49

  2. Kim, Y

    • Effect of cyclosporin on generalized Shwartzman reaction in diabetic rats. Diabetes January 1990 39:83-86; doi:10.2337/diabetes.39.1.83

L

  1. Lapolla, A

    • Absence of brown product FFI in nondiabetic and diabetic rat collagen. Diabetes January 1990 39:57-61; doi:10.2337/diabetes.39.1.57

  2. Law, W R

    • Adenosine reversal of in vivo hepatic responsiveness to insulin. Diabetes January 1990 39:62-69; doi:10.2337/diabetes.39.1.62

  3. Leonetti, D L

    • Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes January 1990 39:104-111; doi:10.2337/diabetes.39.1.104

  4. Loon, N

    • Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes January 1990 39:76-82; doi:10.2337/diabetes.39.1.76

  5. Luzi, L

    • Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes January 1990 39:38-48; doi:10.2337/diabetes.39.1.38

M

  1. Matsutani, A

    • Polymorphisms of HepG2/erythrocyte glucose-transporter gene. Linkage relationships and implications for genetic analysis of NIDDM. Diabetes January 1990 39:49-56; doi:10.2337/diabetes.39.1.49

  2. Mauer, S M

    • Effect of cyclosporin on generalized Shwartzman reaction in diabetic rats. Diabetes January 1990 39:83-86; doi:10.2337/diabetes.39.1.83

  3. McLane, M P

    • Adenosine reversal of in vivo hepatic responsiveness to insulin. Diabetes January 1990 39:62-69; doi:10.2337/diabetes.39.1.62

  4. Meyer, T

    • Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes January 1990 39:76-82; doi:10.2337/diabetes.39.1.76

  5. Miyaji, T

    • Immediate elimination of labile HbA1c with allosteric effectors of hemoglobin. Diabetes January 1990 39:17-21; doi:10.2337/diabetes.39.1.17

  6. Mohan, P S

    • Occurrence of type VI collagen in extracellular matrix of renal glomeruli and its increase in diabetes. Diabetes January 1990 39:31-37; doi:10.2337/diabetes.39.1.31

  7. Morelli, E

    • Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes January 1990 39:76-82; doi:10.2337/diabetes.39.1.76

  8. Mueckler, M

    • Family of glucose-transporter genes. Implications for glucose homeostasis and diabetes. Diabetes January 1990 39:6-11; doi:10.2337/diabetes.39.1.6
    • Polymorphisms of HepG2/erythrocyte glucose-transporter gene. Linkage relationships and implications for genetic analysis of NIDDM. Diabetes January 1990 39:49-56; doi:10.2337/diabetes.39.1.49

  9. Murtaugh, M

    • Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes January 1990 39:118-122; doi:10.2337/diabetes.39.1.118

  10. Myers, B D

    • Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes January 1990 39:76-82; doi:10.2337/diabetes.39.1.76

  11. Myers, S R

    • Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes January 1990 39:87-95; doi:10.2337/diabetes.39.1.87

N

  1. Nakashima, K

    • Immediate elimination of labile HbA1c with allosteric effectors of hemoglobin. Diabetes January 1990 39:17-21; doi:10.2337/diabetes.39.1.17

  2. Nepom, G T

    • HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes January 1990 39:96-103; doi:10.2337/diabetes.39.1.96

  3. Newell-Morris, L L

    • Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes January 1990 39:104-111; doi:10.2337/diabetes.39.1.104

O

  1. O'Brien, T D

    • Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes January 1990 39:118-122; doi:10.2337/diabetes.39.1.118

  2. Oikawa, S

    • Absence of angiogenesis-inhibitory activity in aqueous humor of diabetic rabbits. Diabetes January 1990 39:12-16; doi:10.2337/diabetes.39.1.12

  3. Okamoto, T

    • Absence of angiogenesis-inhibitory activity in aqueous humor of diabetic rabbits. Diabetes January 1990 39:12-16; doi:10.2337/diabetes.39.1.12

P

  1. Pelli, B

    • Absence of brown product FFI in nondiabetic and diabetic rat collagen. Diabetes January 1990 39:57-61; doi:10.2337/diabetes.39.1.57

  2. Permutt, M A

    • Polymorphisms of HepG2/erythrocyte glucose-transporter gene. Linkage relationships and implications for genetic analysis of NIDDM. Diabetes January 1990 39:49-56; doi:10.2337/diabetes.39.1.49

  3. Peters, W

    • Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes January 1990 39:76-82; doi:10.2337/diabetes.39.1.76

  4. Petrides, A S

    • Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes January 1990 39:38-48; doi:10.2337/diabetes.39.1.38

R

  1. Raymond, R M

    • Adenosine reversal of in vivo hepatic responsiveness to insulin. Diabetes January 1990 39:62-69; doi:10.2337/diabetes.39.1.62

  2. Rorsman, F

    • Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes January 1990 39:118-122; doi:10.2337/diabetes.39.1.118

S

  1. Scharf, S

    • HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes January 1990 39:96-103; doi:10.2337/diabetes.39.1.96

  2. Seino, M

    • Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction. Diabetes January 1990 39:123-128; doi:10.2337/diabetes.39.1.123

  3. Seino, S

    • Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction. Diabetes January 1990 39:123-128; doi:10.2337/diabetes.39.1.123

  4. Shechter, Y

    • Insulin-mimetic effects of vanadate. Possible implications for future treatment of diabetes. Diabetes January 1990 39:1-5; doi:10.2337/diabetes.39.1.1

  5. Shuman, W P

    • Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes January 1990 39:104-111; doi:10.2337/diabetes.39.1.104

  6. Simonson, D C

    • Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes January 1990 39:38-48; doi:10.2337/diabetes.39.1.38

  7. Spiro, R G

    • Occurrence of type VI collagen in extracellular matrix of renal glomeruli and its increase in diabetes. Diabetes January 1990 39:31-37; doi:10.2337/diabetes.39.1.31

  8. Sturaro, A

    • Absence of brown product FFI in nondiabetic and diabetic rat collagen. Diabetes January 1990 39:57-61; doi:10.2337/diabetes.39.1.57

  9. Swenne, I

    • Islet cell thymidine kinase activity as indicator of islet cell proliferation in rat pancreas. Diabetes January 1990 39:70-75; doi:10.2337/diabetes.39.1.70

T

  1. Tait, B

    • HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM. Diabetes January 1990 39:96-103; doi:10.2337/diabetes.39.1.96

  2. Takechi, M

    • Immediate elimination of labile HbA1c with allosteric effectors of hemoglobin. Diabetes January 1990 39:17-21; doi:10.2337/diabetes.39.1.17

  3. Thorburn, A W

    • Effect of hyperinsulinemia and hyperglycemia on intracellular glucose and fat metabolism in healthy subjects. Diabetes January 1990 39:22-30; doi:10.2337/diabetes.39.1.22

  4. Toyota, T

    • Absence of angiogenesis-inhibitory activity in aqueous humor of diabetic rabbits. Diabetes January 1990 39:12-16; doi:10.2337/diabetes.39.1.12

  5. Traldi, P

    • Absence of brown product FFI in nondiabetic and diabetic rat collagen. Diabetes January 1990 39:57-61; doi:10.2337/diabetes.39.1.57

  6. Triebwasser, K

    • Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes January 1990 39:87-95; doi:10.2337/diabetes.39.1.87

W

  1. Wahl, P W

    • Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes January 1990 39:104-111; doi:10.2337/diabetes.39.1.104

  2. Westermark, P

    • Structure of cat islet amyloid polypeptide and identification of amino acid residues of potential significance for islet amyloid formation. Diabetes January 1990 39:118-122; doi:10.2337/diabetes.39.1.118

  3. Williams, P E

    • Interaction between insulin and glucose-delivery route in regulation of net hepatic glucose uptake in conscious dogs. Diabetes January 1990 39:87-95; doi:10.2337/diabetes.39.1.87

Y

  1. Yamazaki, K

    • Immediate elimination of labile HbA1c with allosteric effectors of hemoglobin. Diabetes January 1990 39:17-21; doi:10.2337/diabetes.39.1.17

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement